Apland, J. P., Aroniadou-Anderjaska, V., Figueiredo, T. H., Green, C. E., Swezey, R., Yang, C., . . . Braga, M. F. M. (2013). Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model without Pretreatment and its Pharmacokinetics after Intramuscular Administration. The American Society for Pharmacology and Experimental Therapeutics.

Apland, James P., Vassiliki Aroniadou-Anderjaska, Taiza H. Figueiredo, Carol E. Green, Robert Swezey, Chun Yang, Felicia Qashu, and Maria F. M. Braga. Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model Without Pretreatment and Its Pharmacokinetics After Intramuscular Administration. The American Society for Pharmacology and Experimental Therapeutics, 2013.

Apland, James P., et al. Efficacy of the GluK1/AMPA Receptor Antagonist LY293558 against Seizures and Neuropathology in a Soman-Exposure Model Without Pretreatment and Its Pharmacokinetics After Intramuscular Administration. The American Society for Pharmacology and Experimental Therapeutics, 2013.